pf-07220060, a novel oral cdk4-selective inhibitor, in hr /her2- mbc
Published 4 months ago • 574 plays • Length 3:41Download video MP4
Download video MP3
Similar videos
-
2:31
pf-07220060 in hr her2- mbc who progressed on prior cdk4/6 inhibitors and endocrine therapy
-
1:20
updated safety findings of pf-07220060 and endocrine therapy in hr /her2- breast cancer
-
0:57
evaluating the benefits of selective cdk4 inhibition in hr /her2- breast cancer
-
1:02
phase iii trial of pf-07220060 and fulvestrant in hr /her2- breast cancer
-
0:53
postmonarche: abemaciclib fulvestrant in hr /her2- mbc following cdk4/6i & endocrine therapy
-
1:59:33
addressing current questions and controversies in the management of metastatic breast cancer
-
5:58
metastatic breast cancer with bone-only metastases
-
1:14:37
individualizing the selection of first-line therapy for patients with hr-positive metastatic bc
-
2:07
taktic: ipatasertib, endocrine therapy and cdk4/6i for patients with hr /her2- mbc
-
2:06
unmet needs and cdk4/6 inhibitors in hr /her2- early breast cancer
-
2:22
cdk4/6 inhibitors in early stage hr /her2- disease
-
14:31
p-reality-x: real-world, overall survival with palbociclib aromatase inhibitor in hr /her2- mbc
-
3:37
sonia: optimal cdk4/6 inhibitor position in hr , her2- advanced bc
-
1:57
impact of cdk4/6 inhibitors on hr-positive, her2-negative advanced breast cancer
-
5:47
elaine 1: las vs fulv in la er /her2- mbc esr1m disease progression on ai and cdk4/6i inhibitors
-
2:06
exploring novel therapeutic approaches in hr / her2- mbc
-
1:11
unmet needs in the use of cdk4/6 inhibitors in early-stage hr /her2- breast cancer
-
5:16
cdk4/6 inhibitor abemaciclib plus fulvestrant improves overall survival in hr-positive/her2-nega...
-
2:27
understanding abemaciclib: a new cdk4/6 inhibitor
-
1:46
phase i/ii study of a novel serca in er her2- bc
-
1:25
current state of cdk4/6 inhibitors in metastatic her2-negative breast cancer
-
0:46
update of emerald by duration of cdk4/6i in metastatic setting: elacestrant v soc in er /her2- mbc